JP2022174317A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022174317A5 JP2022174317A5 JP2022152235A JP2022152235A JP2022174317A5 JP 2022174317 A5 JP2022174317 A5 JP 2022174317A5 JP 2022152235 A JP2022152235 A JP 2022152235A JP 2022152235 A JP2022152235 A JP 2022152235A JP 2022174317 A5 JP2022174317 A5 JP 2022174317A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- pharmaceutical composition
- oral administration
- seravelisib
- inorganic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 150000007522 mineralic acids Chemical class 0.000 claims 5
- 150000007524 organic acids Chemical class 0.000 claims 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 4
- 229920001477 hydrophilic polymer Polymers 0.000 claims 4
- 239000008203 oral pharmaceutical composition Substances 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 2
- 229930195725 Mannitol Natural products 0.000 claims 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- 235000015165 citric acid Nutrition 0.000 claims 2
- 239000004220 glutamic acid Substances 0.000 claims 2
- 235000013922 glutamic acid Nutrition 0.000 claims 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 2
- 229960003943 hypromellose Drugs 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 239000000594 mannitol Substances 0.000 claims 2
- 235000010355 mannitol Nutrition 0.000 claims 2
- 235000011007 phosphoric acid Nutrition 0.000 claims 2
- 239000006188 syrup Substances 0.000 claims 2
- 235000020357 syrup Nutrition 0.000 claims 2
- 239000011975 tartaric acid Substances 0.000 claims 2
- 235000002906 tartaric acid Nutrition 0.000 claims 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims 1
- 229920002261 Corn starch Polymers 0.000 claims 1
- 239000004386 Erythritol Substances 0.000 claims 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 1
- 235000011054 acetic acid Nutrition 0.000 claims 1
- ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 239000001361 adipic acid Substances 0.000 claims 1
- 235000011037 adipic acid Nutrition 0.000 claims 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims 1
- -1 copolyvidone Polymers 0.000 claims 1
- 239000008120 corn starch Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 235000019414 erythritol Nutrition 0.000 claims 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims 1
- 229940009714 erythritol Drugs 0.000 claims 1
- 239000001530 fumaric acid Substances 0.000 claims 1
- 235000011087 fumaric acid Nutrition 0.000 claims 1
- 229920000578 graft copolymer Polymers 0.000 claims 1
- 235000011167 hydrochloric acid Nutrition 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000001630 malic acid Substances 0.000 claims 1
- 235000011090 malic acid Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 229940068984 polyvinyl alcohol Drugs 0.000 claims 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 229940069328 povidone Drugs 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026010962A JP2026067959A (ja) | 2020-07-02 | 2026-01-27 | 経口用医薬組成物及びその製造方法 |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020114978 | 2020-07-02 | ||
| JP2020114978 | 2020-07-02 | ||
| JP2021011901 | 2021-01-28 | ||
| JP2021011901 | 2021-01-28 | ||
| PCT/JP2021/025019 WO2022004859A1 (ja) | 2020-07-02 | 2021-07-01 | 経口用医薬組成物及びその製造方法 |
| JP2022529745A JP7149449B2 (ja) | 2020-07-02 | 2021-07-01 | 経口用医薬組成物及びその製造方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529745A Division JP7149449B2 (ja) | 2020-07-02 | 2021-07-01 | 経口用医薬組成物及びその製造方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026010962A Division JP2026067959A (ja) | 2020-07-02 | 2026-01-27 | 経口用医薬組成物及びその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022174317A JP2022174317A (ja) | 2022-11-22 |
| JP2022174317A5 true JP2022174317A5 (https=) | 2024-07-03 |
Family
ID=79316406
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529745A Active JP7149449B2 (ja) | 2020-07-02 | 2021-07-01 | 経口用医薬組成物及びその製造方法 |
| JP2022152235A Pending JP2022174317A (ja) | 2020-07-02 | 2022-09-26 | 経口用医薬組成物及びその製造方法 |
| JP2026010962A Pending JP2026067959A (ja) | 2020-07-02 | 2026-01-27 | 経口用医薬組成物及びその製造方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529745A Active JP7149449B2 (ja) | 2020-07-02 | 2021-07-01 | 経口用医薬組成物及びその製造方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026010962A Pending JP2026067959A (ja) | 2020-07-02 | 2026-01-27 | 経口用医薬組成物及びその製造方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230364063A1 (https=) |
| EP (1) | EP4176902A4 (https=) |
| JP (3) | JP7149449B2 (https=) |
| KR (1) | KR20230034207A (https=) |
| CN (1) | CN115989022A (https=) |
| AU (1) | AU2021299348A1 (https=) |
| CA (1) | CA3182166A1 (https=) |
| WO (1) | WO2022004859A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3102279A1 (en) | 2018-06-01 | 2019-12-05 | Cornell University | Combination therapy for pi3k-associated disease or disorder |
| TR2022009483A2 (tr) * | 2022-06-08 | 2023-12-21 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Palbosiklib içeren bir farmasötik bileşim. |
| CN120379674A (zh) * | 2022-12-16 | 2025-07-25 | 阿瑟姆治疗株式会社 | 脉管畸形用药物组合物及脉管畸形的治疗方法 |
| KR20240170460A (ko) * | 2023-05-25 | 2024-12-03 | 주식회사 삼양홀딩스 | 팔보시클립의 경구용 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6287599B1 (en) * | 2000-12-20 | 2001-09-11 | Shire Laboratories, Inc. | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
| GB0517205D0 (en) | 2005-08-22 | 2005-09-28 | Novartis Ag | Organic compounds |
| EP1919460A2 (en) * | 2005-08-22 | 2008-05-14 | Novartis AG | Pharmaceutical compositions comprising a ph-dependent drug, a ph modifier and a retarding agent |
| US9403820B2 (en) * | 2011-11-11 | 2016-08-02 | Intellikine Llc | Kinase inhibitor polymorphs |
| JP6680297B2 (ja) | 2015-04-28 | 2020-04-15 | アステラス製薬株式会社 | 経口投与用医薬組成物 |
| KR102369405B1 (ko) | 2015-06-04 | 2022-03-02 | 화이자 인코포레이티드 | 팔보시클립의 고체 투여 형태 |
| CN105816437B (zh) | 2016-03-29 | 2018-08-03 | 深圳市药欣生物科技有限公司 | 一种帕布昔利布的药物制剂及其制备方法 |
| TWI791053B (zh) * | 2017-10-10 | 2023-02-01 | 美商亞雷生物製藥股份有限公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物 |
-
2021
- 2021-07-01 JP JP2022529745A patent/JP7149449B2/ja active Active
- 2021-07-01 US US18/013,616 patent/US20230364063A1/en active Pending
- 2021-07-01 KR KR1020227041888A patent/KR20230034207A/ko active Pending
- 2021-07-01 CN CN202180044261.1A patent/CN115989022A/zh active Pending
- 2021-07-01 CA CA3182166A patent/CA3182166A1/en active Pending
- 2021-07-01 EP EP21834289.7A patent/EP4176902A4/en active Pending
- 2021-07-01 AU AU2021299348A patent/AU2021299348A1/en active Pending
- 2021-07-01 WO PCT/JP2021/025019 patent/WO2022004859A1/ja not_active Ceased
-
2022
- 2022-09-26 JP JP2022152235A patent/JP2022174317A/ja active Pending
-
2026
- 2026-01-27 JP JP2026010962A patent/JP2026067959A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022174317A5 (https=) | ||
| TWI838340B (zh) | 含有沃諾拉贊的製劑 | |
| JPWO2022004859A5 (https=) | ||
| US20110142942A1 (en) | USE OF pH SENSITIVE COMPOUNDS IN TASTE MASKING OF DRUG SUBSTANCES WITHIN ORAL THIN FILM STRIPS | |
| JP2018100286A (ja) | 経口投与型コルチコステロイド組成物 | |
| UA90881C2 (uk) | Гастрорезистентна фармацевтична композиція, що містить рифаксимін | |
| US20170172929A1 (en) | Pharmaceutical composition containing pregabalin with improved stability and method for preparing same | |
| EP2012754B1 (en) | Oral rapid release pharmaceutical formulation for esomeprazole | |
| CN104873458A (zh) | 一种沃替西汀冻干口腔崩解片及其制备方法 | |
| JP2020518611A (ja) | 水溶解度及びバイオアベイラビリティが改善された組成物 | |
| CN101820866B (zh) | 用于固体剂型的机械保护层 | |
| US20090202630A1 (en) | Orally disintegrating tablet compositions of ranitidine and methods of manufacture | |
| CN101507717B (zh) | 一种治疗消化性溃疡的复方片剂及其制备方法 | |
| US20250332144A1 (en) | Pharmaceutical composition comprising eliglustat | |
| JP7486258B2 (ja) | 口腔内崩壊錠用顆粒、その製造方法および口腔内崩壊錠 | |
| WO2024220974A1 (en) | Rimegepant fast-dissolving films for oral administration | |
| TWI897768B (zh) | 阿哌沙班膜產品用於治療血栓症之用途 | |
| KR20200078146A (ko) | 내산성이 우수한 탐수로신 염산염 함유 제약 조성물 및 이의 제조방법 | |
| TW202227049A (zh) | 鹽酸決奈達隆藥物組合物、其製備方法及應用 | |
| JP2006298811A (ja) | ゲル化抑制製剤の設計 | |
| KR102153894B1 (ko) | 온단세트론 또는 이의 염을 함유하는 구강 붕해형 필름 제제 및 이의 제조방법 | |
| EP3727352B1 (en) | Sheet formulation for oral use | |
| WO2015022703A1 (en) | A stable pharmaceutical composition of fesoterodine hydrochloride | |
| EA046553B1 (ru) | Состав в виде тонкой пластины для перорального применения | |
| JP2019137632A (ja) | イブプロフェン含有錠剤 |